Through studying brain scans and cerebrospinal fluid of healthy adults researchers at Washington University have shown that changes in key biomarkers of Alzheimer’s disease during midlife can help identify those who will develop dementia years later.  The study is published in JAMA Neurology. The current study focused on data gathered over 10 years and involved 169 cognitively normal research participants ages 45 to 75 when they … Continue reading First ever large-scale human study validates multiple biomarkers for Alzheimer’s disease.